EDITOR'S PAGE

As we approach the close of another year, the temptation to evaluate the recent past becomes almost irresistible. But for the medical device industry, 2007 is a tough year to characterize in few words.

On the upside, for instance, the device industry attracted greater investment from venture capitalists this year than ever before. If current investment rates hold, the amount invested in medical device companies in 2007 could reach nearly $4 billion. Such strong support from the investment community bodes well for the medtech pipeline.

Somewhat less happily, however, two key device sectors experienced setbacks during the year that have sent ripples across the entire industry. Companies in the cardiology sector were hardest hit, with decreases in the markets for both cardiac rhythm management and interventional cardiology products. The orthopedics sector also took a step back, as the Department of Justice compelled five industry leaders to sign agreements settling the department's inquiry into sales practices in the sector.

In this issue's roundtable, "Market Challenges for 2008" (page 48), 11 industry experts contribute their thoughts about the forces that have affected the medtech marketplace in 2007—and those that seem poised to reshape the competitive landscape in 2008.

More insights into what's on the horizon for some of medtech's key sectors will be on tap in mid-January, when MX hosts its second annual Medtech Market Outlook Webcast. During this free event, industry experts will provide forecasts for 2008 and beyond. Look for registration details and more information on this year's presenters in upcoming issues of the MX monthly e-newsletter, MX: Issues Update, or on the MX Web site. To access the archived version of "The Medtech Marketplace in 2007," visit http://www.devicelink.com/mx/webcasts/avail_jan31.html.

Copyright ©2007 MX